OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend human life by 10 yearsaccording to MIT Technology Review.
Retro, that is supported by Sam Altmanhas been working with OpenAI for about a year on this research, according to the report. The GPT-4b micro model tries to re-engineer proteins — a specific set called Yamanaka factor — that can turn human skin cells into young stem cells. Retro believes these proteins are a promising step toward building human organs and providing a supply of replacement cells.
The model is slightly different from Google Nobel prize winning AlphaFoldthat predicts the shape of proteins, but it appears to be the first OpenAI model custom-built for biological research. OpenAI and Retro tell MIT Technology Review that they plan to release research on the model and its outputs.
